T cell subset analysis in peripheral blood of children with RSV bronchiolitis

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 77-80

  De Weerd, Willemien ^a   Twilhaar, Wim Nijen ^b   Kimpen, Jan L L ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ARTICLE; BRONCHIOLITIS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; NATURAL KILLER CELL; NEWBORN; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; BRONCHIOLITIS, VIRAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFANT; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS;

EID: 0031808672     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002349     Document Type: Article

References (28)

1. Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498-505.
2. Denny FW. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 1995; 152: S4-S12.
3. Ruuskanen O. Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr 1993; 23: 50-79.
4. Openshaw PJM. Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am J Respir Crit Care Med 1995; 152: S59-62.
5. McIntosh K, Fishaut JM. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol 1980; 26: 94-118.
6. Scott R, Kaul A, Scott M, Chiba Y, Ogra PL. Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans. J Infect Dis 1978; 137: 810-7.
7. Kimpen JLL, Heymans HSA. Respiratory syncytial virus: immunity and immune injury. Immunol Infect Dis 1993; 3: 281-8.
8. McIntosh K. Bronchiolitis and asthma: Possible common pathogenetic pathways. J Allergy Clin Immunol 1976; 57: 595-604.
9. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120: 28-32.
10. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics 1995; 95: 500-5.
11. Welliver RC. RSV and chronic asthma. Lancet 1995; 34: 789-90.
12. Noma T, Mori A, Yoshizawa I. Induction of allergen-specific IL-2 responsiveness of lymphocytes after respiratory syncytial virus infection and prediction of onset of recurrent wheezing and bronchial asthma. J Allergy Clin Immunol 1996; 98: 816-26.
13. Kimpen JLL. Respiratory syncytial virus immunology. Pediatr Allergy Immunol 1996; 7: 86-90.
14. Cannon MJ, Openshaw PJM, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988; 168: 1163-8.
15. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026-33.
16. Isaacs D, Bangham CRM, McMichael AJ. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987; ii: 769-71.
17. Kimpen JLL, Rich GA, Mohar CK, Ogra PL. Mucosal T cell distribution during infection with respiratory syncytial virus. J Med Virol 1992; 36: 172-9.
18. La Via WV, Marks MI, Stutman HR. Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment and prevention. J Pediatr 1992; 121: 503-10.
19. Kimpen JLL, Ogra PL. T-cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus. Clin Exp Immunol 1993; 91: 78-82.
20. Kimpen JLL, Ogra PL. Mucosal T cells recovered after infection with respiratory syncytial virus display a memory/activation phenotype. Pediatr Allergy Immunol 1995; 6: 119-23.
21. Aherne W, Bird T, Court SDM, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23: 7-18.
22. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD, Sewell HF, Milner AD. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71: 428-32.
23. Welliver RC, Kaul TN, Sun M, Ogra PL. Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol 1984; 133: 1925-35.
24. Raes M, Peeters V, Alliet P, Gillis P, Kortleven J, Magerman K, Rummens JL. Peripheral blood T and B lymphocyte subpopulations in infants with acute respiratory syncytial virus bronchiolitis. Pediatr Allergy Immunol 1997; 8: 97-102.
25. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L, Spier S. Cellular immunity is activated and a Th-2 response is associated with early wheezing in infants after bronchiolitis. J Pediatr 1997; 130: 584-93.
26. Roman M, Calhoun WJ, Hinton KL, Avendaño LF, Simon V, Escobar AM, Gaggero A, Díaz PV. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156: 190-5.
27. Garofalo R, Sabry M, Jamaluddin M, Yu RK, Casola A, Ogra PL, Brasier AR. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J Virol 1996; 70: 8773-81.
28. Fiedler MA, Wernke-Dollries K, Stark JM. Inhibition of viral replication reverses respiratory syncytial virus-induced NF-êB activation and interleukin-8 gene expression in A549 cells. J Virol 1996; 70: 9079-82.